LSB Industries reports Q1 2026 results on April 30 with one signal dominating the setup: insiders have been steady sellers into a rising stock.
The selling is hard to ignore. Todd Boehly, the company's largest individual shareholder, offloaded nearly 4.9 million shares on March 26 at $14.85 each — a disposal worth roughly $72.6 million that trimmed his stake to about 14.5% of the company. CEO Mark Behrman sold 250,000 shares at $11.75 in early March. CFO Cheryl Maguire followed with a $300,000 sale days later. In aggregate, net insider selling reached nearly 5.4 million shares over the past 90 days, totalling more than $78 million. The stock has since climbed to $15.20, up 5.3% on the week — meaning those who sold in March did so below the current market price, yet the volume and breadth of the selling across three senior figures is notable in its own right.
The analyst community sits in a holding pattern heading into the print. All three covering analysts rate LXU a Hold, with a mean price target of $15.10 — fractionally below where the stock closed yesterday. That tight gap between target and price reflects a market that has largely repriced the recovery story. RBC Capital downgraded to Sector Perform on April 7, raising its target to $14.00 even as it cut its conviction — a signal that the upside case has narrowed. UBS lifted its target sharply to $16.50 in late March from $9.75, and Jefferies moved similarly, nudging to $15.00. The direction of travel has been higher targets, but the rating consensus hasn't budged off Hold. EPS momentum is a genuine bright spot — the company ranks in the 97th percentile on 90-day EPS momentum — yet the 12-month forward EPS growth estimate trails badly, ranking just 35th percentile, suggesting the recent earnings improvement may already be fading into consensus expectations.
Short interest is a non-story here. At just 1.6% of the free float, and down roughly 34% over the past week, bears have been covering rather than pressing. Borrowing costs run below 0.6% annually, and the lending market remains wide open. Options positioning tells a similarly relaxed story: the put/call ratio of 0.04 is well below the already-low 52-week high of 0.25, with the z-score barely above zero. There is no meaningful hedging pressure in evidence. Peer chemicals names — CF, LYB, UAN — all traded within a tight band on the week, suggesting no sector-wide catalyst pulling in either direction.
The Q1 print therefore becomes a test of whether LXU's ammonia-driven earnings recovery can sustain the pace that drove the stock's 16% single-day jump after its last quarterly release — and whether the margin and free cash flow profile can justify a valuation that the analysts who follow it most closely now describe as roughly fair.
See the live data behind this article on ORTEX.
Open LXU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
